Tandem Diabetes Care’s new CEO inherits a growing $1bn business. Can she deliver profitability?
Tandem Diabetes Care names Jeannette Bankes CEO amid 14% sales growth. Examine her strategy, $10 million equity award and profitability outlook.
Pharma & Biotech
Pharma & Biotech
Alcon’s new eye drops last up to 12 hours. Can BRYTLY challenge Lumify?
The FDA has approved BRYTLY, Alcon's 0.125% apraclonidine eye drops, for temporary relief of redness caused by minor irritation in people aged 12 and older. Alcon claims effects within one minute lasting up to 12 hours, although its longer-duration comparison with Lumify is based on product labeling rather than a disclosed head-to-head trial.
Medical Devices & Diagnostics
Why Alcon and Aravind’s 60-trainee retina surgery hub could matter far beyond Coimbatore
Aravind Eye Care System and Alcon open a Coimbatore retina training hub aimed at expanding vitreoretinal surgical expertise worldwide.
Medical Devices & Diagnostics
i-Lumen Scientific begins U.S. pivotal trial of microcurrent therapy for dry AMD
i-Lumen Scientific, Inc. has randomized the first United States patient in its pivotal i-SIGHT2 study, beginning the domestic phase of a multinational trial evaluating whether low-level electrical stimulation delivered through a closed eyelid can improve visual function in people with intermediate-to-advanced dry age-related macular degeneration. The first U.S. randomization occurred at Texas Retina Associates in
Medical Devices & Diagnostics
Alcon is paying RxSight $60m upfront to make premium cataract lenses adjustable after surgery
Alcon and RxSight will develop adjustable presbyopia-correcting intraocular lenses that could allow surgeons to refine vision after cataract surgery, although the programme still faces clinical, regulatory and workflow risks.
Pharma & Biotech
Can Alcon turn baseball fandom into a growth engine for Systane in Canada’s dry eye category?
See how Alcon is using the Toronto Blue Jays to expand Systane’s dry eye reach in Canada and what it means for eye care competition.
Medical Devices & Diagnostics
Is Alcon redefining the enhanced monofocal category with Clareon TruPlus at ASCRS 2026?
Alcon launched Clareon TruPlus at ASCRS 2026. Read why the new enhanced monofocal IOL could reshape cataract lens choice.
Medical Devices & Diagnostics
Why Alcon’s TOTAL30 Multifocal for Astigmatism targets the toughest segment in contact lens care
Alcon has launched TOTAL30 Multifocal for Astigmatism in the U.S. Find out why this matters for presbyopia care and contact lens adoption.